º»¹®/³»¿ë
_SLIDE_1_
Pharmaceutical industry Dong-A, Yuhan, Hanmi
_SLIDE_2_
Contents
1. Introduction
2. Companies` profile
(1) µ¿¾ÆÁ¦¾à
(2) À¯ÇѾçÇà
(3) Çѹ̾àǰ
3. Financial Ratio
4. Stock Information
5. Conclusion
_SLIDE_3_
Introduction
New medicine
Generic market
_SLIDE_4_
Introduction
The type of drug market is becoming advanced
Expanding facilities to meet international standards
Ability to invest is needed
_SLIDE_5_
Profile
Dong-A
No.1 pharmaceutical company for 40years
Strong at biotechnology
¹ÚÄ«½ºF, ÆÇÇǸ°F, ½áÅ¥¶õ, ¾Ï¾¾·Õ
_SLIDE_6_
Profile-DongA
History
³âµµ
³»¿ë
1932
¼¿ï Ưº°½Ã Á¾·Î±¸ ÁßÇе¿¿¡¼ ÀǾàǰ ¹× À§»ýÀç·á µµ¸Å¾÷À¸·Î â¾÷
1949
µ¿¾ÆÁ¦¾àÁÖ½Äȸ»ç·Î »ç¸íÀ» º¯°æ
1957
¼¿ï µ¿´ë¹®±¸ ¿ëµÎµ¿¿¡ Çö´ë½Ä °øÀå°ú ¡¦(»ý·«)
he society that raised the company¡¯
Separation of capital and management
_SLIDE_10_
Profile-Yuhan
³âµµ
³»¿ë
1970
9¿ù17ÀÏ À¯ÀÏÇÑ ¹Ú»ç `Çѱ¹»çȸ ¹× ±³À°¿øÁ¶½Åʱâ±Ý` ¼³¸³(À¯ÇÑÀç´Ü Àü½Å)
1971
¼³¸³ÀÚ À¯ÀÏÇÑ ¹Ú»ç ¿µ¸é, Àç»ê À¯ÇÑÀç´Ü¿¡ À¯Áõ
1977
`Àç´Ü¹ýÀÎ À¯ÇÑÀç´Ü`À¸·Î ¸íĪÀ» º¯°æÇÏ°í ¼ÒÀ¯ÁÖ½Ä ÀϺθ¦ Çб³¹ýÀÎ À¯ÇÑÇпø°ú ºÐÇÒ.
1981
¼¿ï´ë ¾àÇдëÇп¡ ÀåÇбâ±ÝÀ¸·Î À¯ÇѾçÇà ÁÖ½Ä 2¸¸ÁÖ ±âÁõ
1987
±³À°»ç¾÷, ÀåÇлç¾÷ ¿Ü¿¡ Àå¾ÖÀÎ Áö¿ø»ç¾÷ °³½Ã
1991
À¯Àç¶ó ¿©»ç(À¯ÀÏÇÑ ¹Ú»ç ¿©½Ä) ¿µ¸é, Àü Àç»ê À¯ÇÑÀç´Ü¿¡ À¯Áõ
1991
»çȸº¹Áö»ç¾÷À» ½Å±Ô»ç¾÷À¸·Î¼ ¸ñÀû»ç¾÷¿¡ Ãß°¡ »ç¾÷ °³½Ã
1992
`Á¦1ȸ À¯Àç¶ó ºÀ»ç»ó` ½Ã»ó
1992
`Á¦1ȸ Àü±¹ û¼Ò³â ±ÛÁþ±â ´ëȸ` °³ÃÖ
1995
`Á¦1ȸ À¯ÀÏÇÑ »ó` ½Ã»ó
1995
À¯¼øÇÑ ¿©»ç(À¯ÀÏÇÑ ¹Ú»ç µ¿»ý), À¯ÇѾçÇà ÁÖ½Ä ±âÁõ
1998
À¯Àç¶ó ºÀ»ç»ó ¿©¾à»ç ºÎ¹® ½Ã»ó
2000
Àϰ¡»ó ¼ö»ó
_SLIDE_11_
Profile-Yuhan
Subsidiaries
Ownership composition
°ü°è»ç¸í
ÁöºÐÀ²
°ü°è»ç¸í
ÁöºÐÀ²
(ÁÖ)À¯ÇѸ޵ðÄ«
100.00
(ÁÖ)À¯ÇÑÅ©·Î¶ô½º
50.00
(ÁÖ)À¯ÇÑÈÇÐ
100.00
´ëÇ¥ÁÖÁÖ
º¸°íÀÚ
º¸À¯Áֽļö
º¸À¯ÁöºÐ (%)
ÃÖÁ¾°Å·¡ÀÏ
º¯µ¿Áֽļö
º¯µ¿ÁöºÐ (%)
º¯µ¿»çÀ¯
À¯ÇÑÀç´Ü
À¯ÇÑÀç´Ü
1,635,827
15.39
09/12/29
77,901
0.00
¹«»ó½ÅÁÖÃëµæ..
¿¬¸¸Èñ
21,269
0.20
09/12/29
1,695
0.00
¹«»ó½ÅÁÖÃëµæ..
ÃÖ»óÈÄ
2,124
0.02
10/05/27
1
0.00
Àå³»¸Å¼ö(+)
IL LING H. N..
256
0.00
09/12/29
12
0.00
¹«»ó½ÅÁÖÃëµæ..
±èÀ±¼·